Nurix Therapeutics, Inc. — 8-K Filings
73 8-K filings on record
This page lists all 8-K filings submitted to the SEC by Nurix Therapeutics, Inc. (NRIX), sorted by most recent first. Each row links to the full filing on EdgarLookup. Nurix Therapeutics, Inc. has filed 73 8-K documents with the SEC since 2012. To view all SEC filings by Nurix Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
3
4
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
POS AM
POS EX
POSASR
S-1
S-1/A
S-3ASR
S-8
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K | 0001193125-22-160275 | May 26, 2022 | — |
| 8-K | 8-K | 0001193125-22-150768 | May 16, 2022 | May 15, 2022 |
| 8-K | 8-K | 0001193125-22-142944 | May 6, 2022 | May 5, 2022 |
| 8-K | 8-K | 0001564590-22-013841 | Apr 7, 2022 | — |
| 8-K | 8-K | 0001193125-22-067928 | Mar 7, 2022 | Mar 2, 2022 |
| 8-K | 8-K | 0001193125-22-062963 | Mar 2, 2022 | Mar 1, 2022 |
| 8-K | 8-K | 0001564590-22-002664 | Jan 27, 2022 | — |
| 8-K | 8-K | 0001193125-22-005046 | Jan 10, 2022 | — |
| 8-K | 8-K | 0001193125-21-308663 | Oct 27, 2021 | — |
| 8-K | 8-K | 0001564590-21-050869 | Oct 14, 2021 | — |
| 8-K | 8-K | 0001193125-21-287318 | Sep 30, 2021 | Sep 25, 2021 |
| 8-K | 8-K | 0001564590-21-036443 | Jul 13, 2021 | — |
| 8-K | 8-K | 0001193125-21-211877 | Jul 9, 2021 | Jul 8, 2021 |
| 8-K | 8-K | 0001193125-21-195077 | Jun 21, 2021 | Jun 14, 2021 |
| 8-K | 8-K | 0001193125-21-179209 | Jun 2, 2021 | — |
| 8-K | 8-K | 0001193125-21-178533 | Jun 1, 2021 | May 28, 2021 |
| 8-K | 8-K | 0001193125-21-155518 | May 10, 2021 | May 6, 2021 |
| 8-K | 8-K | 0001564590-21-018690 | Apr 13, 2021 | — |
| 8-K | 8-K | 0001564590-21-006066 | Feb 16, 2021 | — |
| 8-K | 8-K | 0001193125-20-311095 | Dec 7, 2020 | — |
| 8-K | 8-K | 0001193125-20-276906 | Oct 26, 2020 | Oct 23, 2020 |
| 8-K | 8-K | 0001564590-20-046402 | Oct 14, 2020 | — |
| 8-K | 8-K | 0001193125-20-269223 | Oct 14, 2020 | — |